• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然多羟基类黄酮、姜黄素类和合成姜黄素类似物作为α7 nAChRs 正变构调节剂。

Natural Polyhydroxy Flavonoids, Curcuminoids, and Synthetic Curcumin Analogs as α7 nAChRs Positive Allosteric Modulators.

机构信息

Instituto de Química Médica-Consejo Superior de Investigaciones Científicas (IQM-CSIC), Juan de la Cierva 3, 28006 Madrid, Spain.

Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, 03050 Sant Joan d'Alacant, Spain.

出版信息

Int J Mol Sci. 2021 Jan 19;22(2):973. doi: 10.3390/ijms22020973.

DOI:10.3390/ijms22020973
PMID:33478095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7835927/
Abstract

The α7 nicotinic acetylcholine receptor (α7 nAChR) is a ligand-gated ion channel that is involved in cognition disorders, schizophrenia, pain, and inflammation. Allosteric modulation of this receptor might be advantageous to reduce the toxicity in comparison with full agonists. Our previous results obtained with some hydroxy-chalcones, which were identified as positive allosteric modulators (PAMs) of α7 nAChR, prompted us to evaluate the potential of some structurally related naturally occurring flavonoids and curcuminoids and some synthetic curcumin analogues, with the aim of identifying new allosteric modulators of the α7 nAChR. Biological evaluation showed that phloretin, demethoxycurcumin, and bis-demethoxicurcuming behave as PAMs of α7 nAChR. In addition, some new curcumin derivatives were able to enhance the signal evoked by ACh; the activity values found for the tetrahydrocurcuminoid analog were especially promising.

摘要

α7 烟碱型乙酰胆碱受体(α7 nAChR)是一种配体门控离子通道,与认知障碍、精神分裂症、疼痛和炎症有关。与完全激动剂相比,该受体的变构调节可能具有降低毒性的优势。我们之前用一些查尔酮获得的结果表明,它们是 α7 nAChR 的正变构调节剂(PAMs),这促使我们评估一些结构相关的天然黄酮类化合物和姜黄素类化合物以及一些合成姜黄素类似物的潜力,以鉴定 α7 nAChR 的新变构调节剂。生物评价表明,根皮素、去甲氧基姜黄素和双去甲氧基姜黄素是 α7 nAChR 的 PAMs。此外,一些新的姜黄素衍生物能够增强 ACh 引发的信号;四氢姜黄素类似物的活性值特别有希望。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fc/7835927/15ea347e4f00/ijms-22-00973-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fc/7835927/be847e83396a/ijms-22-00973-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fc/7835927/3894d69982df/ijms-22-00973-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fc/7835927/982d89425233/ijms-22-00973-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fc/7835927/15ea347e4f00/ijms-22-00973-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fc/7835927/be847e83396a/ijms-22-00973-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fc/7835927/3894d69982df/ijms-22-00973-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fc/7835927/982d89425233/ijms-22-00973-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fc/7835927/15ea347e4f00/ijms-22-00973-g002.jpg

相似文献

1
Natural Polyhydroxy Flavonoids, Curcuminoids, and Synthetic Curcumin Analogs as α7 nAChRs Positive Allosteric Modulators.天然多羟基类黄酮、姜黄素类和合成姜黄素类似物作为α7 nAChRs 正变构调节剂。
Int J Mol Sci. 2021 Jan 19;22(2):973. doi: 10.3390/ijms22020973.
2
Identification by virtual screening and functional characterisation of novel positive and negative allosteric modulators of the α7 nicotinic acetylcholine receptor.通过虚拟筛选和功能表征鉴定 α7 烟碱型乙酰胆碱受体的新型正、负变构调节剂。
Neuropharmacology. 2018 Sep 1;139:194-204. doi: 10.1016/j.neuropharm.2018.07.009. Epub 2018 Jul 20.
3
Allosteric Agonism of 7 Nicotinic Acetylcholine Receptors: Receptor Modulation Outside the Orthosteric Site.7 型烟碱型乙酰胆碱受体的变构激动作用:变构部位以外的受体调节。
Mol Pharmacol. 2019 Jun;95(6):606-614. doi: 10.1124/mol.119.115758. Epub 2019 Apr 3.
4
Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes.结构多样的化学类型揭示了α7烟碱型乙酰胆碱受体阳性变构调节的不同特征。
Mol Pharmacol. 2007 Sep;72(3):715-24. doi: 10.1124/mol.107.035410. Epub 2007 Jun 12.
5
PNU-120596, a positive allosteric modulator of mammalian α7 nicotinic acetylcholine receptor, is a negative modulator of ligand-gated chloride-selective channels of the gastropod Lymnaea stagnalis.PNU-120596 是一种哺乳动物 α7 烟碱型乙酰胆碱受体的正变构调节剂,也是腹足纲动物田螺 Lymnaea stagnalis 配体门控氯离子选择性通道的负变构调节剂。
J Neurochem. 2020 Nov;155(3):274-284. doi: 10.1111/jnc.15020. Epub 2020 Apr 19.
6
Potentiation and allosteric agonist activation of α7 nicotinic acetylcholine receptors: binding sites and hypotheses.α7 型烟碱型乙酰胆碱受体的增效作用和变构激动剂激活:结合位点和假说。
Pharmacol Res. 2023 May;191:106759. doi: 10.1016/j.phrs.2023.106759. Epub 2023 Apr 4.
7
Allosterically Potentiated 7 Nicotinic Acetylcholine Receptors: Reduced Calcium Permeability and Current-Independent Control of Intracellular Calcium.变构增强的 7 型烟碱型乙酰胆碱受体:降低钙通透性和钙内流的电流非依赖性调控。
Mol Pharmacol. 2020 Dec;98(6):695-709. doi: 10.1124/molpharm.120.000012. Epub 2020 Oct 5.
8
Flavonoids as positive allosteric modulators of α7 nicotinic receptors.黄酮类化合物作为 α7 烟碱型乙酰胆碱受体的正变构调节剂。
Neuropharmacology. 2019 Dec 1;160:107794. doi: 10.1016/j.neuropharm.2019.107794. Epub 2019 Sep 24.
9
Advances in the discovery of novel positive allosteric modulators of the alpha7 nicotinic acetylcholine receptor.α7烟碱型乙酰胆碱受体新型正变构调节剂的发现进展
Recent Pat CNS Drug Discov. 2007 Jun;2(2):99-106. doi: 10.2174/157488907780832751.
10
Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study.I 型和 II 型正变构调节剂与人 α7 烟碱型乙酰胆碱受体的分子相互作用:一项计算机研究。
J Biomol Struct Dyn. 2019 Feb;37(2):411-439. doi: 10.1080/07391102.2018.1427634. Epub 2018 Feb 16.

引用本文的文献

1
Competitive Antagonism of Xylazine on α7 Nicotinic Acetylcholine Receptors and Reversal by Curcuminoids.赛拉嗪对α7烟碱型乙酰胆碱受体的竞争性拮抗作用及姜黄素类化合物的逆转作用
ACS Chem Neurosci. 2025 Jan 15;16(2):232-240. doi: 10.1021/acschemneuro.4c00784. Epub 2024 Dec 25.
2
Apigenin Alleviates Autistic-like Stereotyped Repetitive Behaviors and Mitigates Brain Oxidative Stress in Mice.芹菜素减轻小鼠自闭症样刻板重复行为并缓解脑氧化应激
Pharmaceuticals (Basel). 2024 Apr 9;17(4):482. doi: 10.3390/ph17040482.
3
Quercetin Derivatives as Potential Therapeutic Agents: An Updated Perspective on the Treatment of Nicotine-Induced Non-Small Cell Lung Cancer.

本文引用的文献

1
Current Perspectives of the Applications of Polyphenols and Flavonoids in Cancer Therapy.多酚和类黄酮在癌症治疗中的应用的当前观点。
Molecules. 2020 Jul 23;25(15):3342. doi: 10.3390/molecules25153342.
2
Allosterism of Nicotinic Acetylcholine Receptors: Therapeutic Potential for Neuroinflammation Underlying Brain Trauma and Degenerative Disorders.乙酰胆碱受体变构调节:脑创伤和退行性疾病相关神经炎症的治疗潜力。
Int J Mol Sci. 2020 Jul 12;21(14):4918. doi: 10.3390/ijms21144918.
3
The Emerging Role of Nutraceuticals and Phytochemicals in the Prevention and Treatment of Alzheimer's Disease.
槲皮素衍生物作为潜在的治疗剂:尼古丁诱导的非小细胞肺癌治疗的最新视角。
Int J Mol Sci. 2023 Oct 15;24(20):15208. doi: 10.3390/ijms242015208.
4
Curcumin and Its Analogs in Non-Small Cell Lung Cancer Treatment: Challenges and Expectations.姜黄素及其类似物在非小细胞肺癌治疗中的应用:挑战与展望。
Biomolecules. 2022 Nov 4;12(11):1636. doi: 10.3390/biom12111636.
5
Curcumin Potentiates α7 Nicotinic Acetylcholine Receptors and Alleviates Autistic-Like Social Deficits and Brain Oxidative Stress Status in Mice.姜黄素增强 α7 烟碱型乙酰胆碱受体,减轻小鼠自闭症样社交缺陷和大脑氧化应激状态。
Int J Mol Sci. 2021 Jul 6;22(14):7251. doi: 10.3390/ijms22147251.
6
Apigenin and Structurally Related Flavonoids Allosterically Potentiate the Function of Human α7-Nicotinic Acetylcholine Receptors Expressed in SH-EP1 Cells.芹菜素和结构相关的类黄酮变构增强人α7-烟碱型乙酰胆碱受体在 SH-EP1 细胞中的功能。
Cells. 2021 May 5;10(5):1110. doi: 10.3390/cells10051110.
营养保健品和植物化学物质在预防和治疗阿尔茨海默病中的新兴作用。
J Alzheimers Dis. 2020;77(1):33-51. doi: 10.3233/JAD-200443.
4
Curcumin in cancer therapy: A novel adjunct for combination chemotherapy with paclitaxel and alleviation of its adverse effects.姜黄素在癌症治疗中的应用:作为紫杉醇联合化疗的辅助药物,减轻其不良反应。
Life Sci. 2020 Sep 1;256:117984. doi: 10.1016/j.lfs.2020.117984. Epub 2020 Jun 25.
5
Immunomodulatory therapeutic effects of curcumin in rheumatoid arthritis.姜黄素在类风湿性关节炎中的免疫调节治疗作用。
Autoimmun Rev. 2020 Aug;19(8):102593. doi: 10.1016/j.autrev.2020.102593. Epub 2020 Jun 12.
6
The Cancer Chemopreventive and Therapeutic Potential of Tetrahydrocurcumin.四氢姜黄素的抗癌化学预防和治疗潜力。
Biomolecules. 2020 May 29;10(6):831. doi: 10.3390/biom10060831.
7
Selective α7 nicotinic receptor agonists and positive allosteric modulators for the treatment of schizophrenia - a review.选择性 α7 烟碱型乙酰胆碱受体激动剂和正变构调节剂治疗精神分裂症的研究进展
Expert Opin Investig Drugs. 2020 Jun;29(6):603-610. doi: 10.1080/13543784.2020.1764938. Epub 2020 May 12.
8
Role of Flavonoids in Neurodegenerative Diseases: Limitations and Future Perspectives.黄酮类化合物在神经退行性疾病中的作用:局限性和未来展望。
Curr Top Med Chem. 2020;20(13):1169-1194. doi: 10.2174/1568026620666200416085330.
9
α7 nicotinic acetylcholine receptors as therapeutic targets in schizophrenia: Update on animal and clinical studies and strategies for the future.α7 烟碱型乙酰胆碱受体在精神分裂症中的治疗靶点:动物和临床研究的最新进展及未来策略。
Neuropharmacology. 2020 Jun 15;170:108053. doi: 10.1016/j.neuropharm.2020.108053. Epub 2020 Mar 15.
10
Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease.分子洞察类黄酮治疗阿尔茨海默病的潜力。
Molecules. 2020 Mar 11;25(6):1267. doi: 10.3390/molecules25061267.